{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:04:16Z","timestamp":1787497456275,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["ALH 2017-02051"],"award-info":[{"award-number":["ALH 2017-02051"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["150785"],"award-info":[{"award-number":["150785"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.rbmo.2020.01.032","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T23:55:18Z","timestamp":1581724518000},"page":"128-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Endometrial expression of anti-M\u00fcllerian hormone and its type II receptor in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"41","author":[{"given":"Mariana","family":"Paulson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Sahlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica Lind\u00e9n","family":"Hirschberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2020.01.032_bib0001","doi-asserted-by":"crossref","unstructured":"Al-Sabbagh, M., Lam, E.W.F., Brosens, J.J., 2012. Mechanisms of endometrial progesterone resistance. Mol. Cell. Endocrinol.https:\/\/doi.org\/10.1016\/j.mce.2011.10.035","DOI":"10.1016\/j.mce.2011.10.035"},{"key":"10.1016\/j.rbmo.2020.01.032_bib0002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2007.09.010","article-title":"M\u00fcllerian inhibiting substance type II receptor (MISIIR): A novel, tissue-specific target expressed by gynecologic cancers","volume":"108","author":"Bakkum-Gamez","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.rbmo.2020.01.032_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2011.03.021","article-title":"Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome","volume":"95","author":"Bellver","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2020.01.032_bib0004","doi-asserted-by":"crossref","unstructured":"Carrarelli, P., Rocha, A.L.L., Belmonte, G., Zupi, E., Abr\u00e3o, M.S., Arcuri, F., Piomboni, P., Petraglia, F., 2014. Increased expression of antim\u00fcllerian hormone and its receptor in endometriosis. Fertil. Steril.https:\/\/doi.org\/10.1016\/j.fertnstert.2014.01.052","DOI":"10.1016\/j.fertnstert.2014.01.052"},{"key":"10.1016\/j.rbmo.2020.01.032_bib0005","doi-asserted-by":"crossref","unstructured":"Chang, H.L., Pieretti-Vanmarcke, R., Nicolaou, F., Li, X., Wei, X., MacLaughlin, D.T., Donahoe, P.K., 2011. Mullerian Inhibiting Substance inhibits invasion and migration of epithelial cancer cell lines. Gynecol. Oncol.https:\/\/doi.org\/10.1016\/j.ygyno.2010.09.017","DOI":"10.1016\/j.ygyno.2010.09.017"},{"key":"10.1016\/j.rbmo.2020.01.032_bib0006","doi-asserted-by":"crossref","unstructured":"Cook, C.L., Siow, Y., Taylor, S., Fallat, M.E., 2000. Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil. Steril.https:\/\/doi.org\/10.1016\/S0015-0282(99)00639-1","DOI":"10.1016\/S0015-0282(99)00639-1"},{"key":"10.1016\/j.rbmo.2020.01.032_bib0007","doi-asserted-by":"crossref","unstructured":"Dumont, A., Robin, G., Catteau-Jonard, S., Dewailly, D., 2015. Role of Anti-M\u00fcllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: A review. Reprod. Biol. Endocrinol.https:\/\/doi.org\/10.1186\/s12958-015-0134-9","DOI":"10.1186\/s12958-015-0134-9"},{"key":"10.1016\/j.rbmo.2020.01.032_bib0008","doi-asserted-by":"crossref","unstructured":"Giudice, L.C., 2006. Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best Pract. Res. Clin. Endocrinol. Metab.https:\/\/doi.org\/10.1016\/j.beem.2006.03.005","DOI":"10.1016\/j.beem.2006.03.005"},{"key":"10.1016\/j.rbmo.2020.01.032_bib0009","doi-asserted-by":"crossref","unstructured":"Goodarzi, M.O., Dumesic, D.A., Chazenbalk, G., Azziz, R., 2011. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nat. Rev. Endocrinol.https:\/\/doi.org\/10.1038\/nrendo.2010.217","DOI":"10.1038\/nrendo.2010.217"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00010","doi-asserted-by":"crossref","unstructured":"Gowkielewicz, M., Lipka, A., Piotrowska, A., Szadurska-Noga, M., Nowakowski, J.J., Dzi\u0119giel, P., Majewski, M.K., Jozwik, M., Majewska, M., 2019. Anti-m\u00fcllerian hormone expression in endometrial cancer tissue. Int. J. Mol. Sci.https:\/\/doi.org\/10.3390\/ijms20061325","DOI":"10.3390\/ijms20061325"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00011","doi-asserted-by":"crossref","unstructured":"Hulchiy, M., Nybacka, \u00c5., Sahlin, L., Hirschberg, A.L., 2016. Endometrial expression of estrogen receptors and the androgen receptor in women with polycystic ovary syndrome: A lifestyle intervention study. J. Clin. Endocrinol. Metab.https:\/\/doi.org\/10.1210\/jc.2015-3803","DOI":"10.1210\/jc.2015-3803"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00012","doi-asserted-by":"crossref","unstructured":"Hulchiy, M., Zhang, H., Cline, J.M., Hirschberg, A.L., Sahlin, L., 2012. Effects of long-term tibolone treatment on nuclear sex steroid hormone receptors and G-protein-coupled estrogen receptor-1 expression in the macaque uterus. Menopause.https:\/\/doi.org\/10.1097\/gme.0b013e318230f3be","DOI":"10.1097\/gme.0b013e318230f3be"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00013","doi-asserted-by":"crossref","unstructured":"Jonard, S., Dewailly, D., 2004. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum. Reprod. Update.https:\/\/doi.org\/10.1093\/humupd\/dmh010","DOI":"10.1093\/humupd\/dmh010"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00014","doi-asserted-by":"crossref","unstructured":"Larsen, T.M., Dalskov, S.-M., van Baak, M., Jebb, S.A., Papadaki, A., Pfeiffer, A.F.H., Martinez, J.A., Handjieva-Darlenska, T., Kune\u0161ov\u00e1, M., Pihlsg\u00e5rd, M., Stender, S., Holst, C., Saris, W.H.M., Astrup, A., 2010. Diets with High or Low Protein Content and Glycemic Index for Weight-Loss Maintenance. N. Engl. J. Med.https:\/\/doi.org\/10.1056\/NEJMoa1007137","DOI":"10.1056\/NEJMoa1007137"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00015","doi-asserted-by":"crossref","unstructured":"Ledger, W.L., 2010. Clinical utility of measurement of anti-m\u00fcllerian hormone in reproductive endocrinology. J. Clin. Endocrinol. Metab.https:\/\/doi.org\/10.1210\/jc.2010-0701","DOI":"10.1210\/jc.2010-0701"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00016","doi-asserted-by":"crossref","unstructured":"Moran, L.J., Hutchison, S.K., Norman, R.J., Teede, H.J., 2011. Lifestyle changes in women with polycystic ovary syndrome. [Review][Update of Cochrane Database Syst Rev. 2011;(2):CD007506; PMID: 21328294]. Cochrane Database Syst. Rev. http:\/\/doi.org\/http:\/\/dx.doi.org\/10.1002\/14651858.CD007506.pub3","DOI":"10.1002\/14651858.CD007506.pub3"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00017","doi-asserted-by":"crossref","unstructured":"Paulson, M., Sahlin, L., Hirschberg, A.L., 2017. Progesterone receptors and proliferation of the endometrium in obese women with polycystic ovary syndrome-a lifestyle intervention study. J. Clin. Endocrinol. Metab.http:\/\/doi.org\/10.1210\/jc.2016-3155","DOI":"10.1210\/jc.2016-3155"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00018","doi-asserted-by":"crossref","unstructured":"Piltonen, T., Morin-Papunen, L., Koivunen, R., Perheentupa, A., Ruokonen, A., Tapanainen, J.S., 2005. Serum anti-M\u00fcllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum. Reprod.https:\/\/doi.org\/10.1093\/humrep\/deh850","DOI":"10.1093\/humrep\/deh850"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00019","doi-asserted-by":"crossref","unstructured":"Piltonen, T.T., 2016. Polycystic ovary syndrome: Endometrial markers. Best Pract. Res. Clin. Obstet. Gynaecol.https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.03.008","DOI":"10.1016\/j.bpobgyn.2016.03.008"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00020","doi-asserted-by":"crossref","unstructured":"Renaud, E.J., MacLaughlin, D.T., Oliva, E., Rueda, B.R., Donahoe, P.K., 2005. Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance. Proc. Natl. Acad. Sci.https:\/\/doi.org\/10.1073\/pnas.0407772101","DOI":"10.1073\/pnas.0407772101"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00021","doi-asserted-by":"crossref","unstructured":"Rosenfield, R.L., Ehrmann, D.A., 2016. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr. Rev.https:\/\/doi.org\/10.1210\/er.2015-1104","DOI":"10.1210\/er.2015-1104"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00022","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00023","doi-asserted-by":"crossref","unstructured":"Savaris, R.F., Groll, J.M., Young, S.L., DeMayo, F.J., Jeong, J.W., Hamilton, A.E., Giudice, L.C., Lessey, B.A., 2011. Progesterone resistance in PCOS endometrium: A microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. J. Clin. Endocrinol. Metab.https:\/\/doi.org\/10.1210\/jc.2010-2600","DOI":"10.1097\/OGX.0b013e31823b65c3"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00024","doi-asserted-by":"crossref","unstructured":"Shang, K., Jia, X., Qiao, J., Kang, J., Guan, Y., 2012. Endometrial abnormality in women with polycystic ovary syndrome. Reprod. Sci.https:\/\/doi.org\/10.1177\/1933719111430993","DOI":"10.1177\/1933719111430993"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00025","doi-asserted-by":"crossref","unstructured":"Signorile, P.G., Petraglia, F., Baldi, A., 2014. Anti-mullerian hormone is expressed by endometriosis tissues and induces cell cycle arrest and apoptosis in endometriosis cells. J. Exp. Clin. Cancer Res.https:\/\/doi.org\/10.1186\/1756-9966-33-46","DOI":"10.1186\/1756-9966-33-46"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00026","doi-asserted-by":"crossref","unstructured":"Ujvari, D., Hulchiy, M., Calaby, A., Nybacka, A., Bystr\u00f6m, B., Hirschberg, A.L., 2014. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight\/obese women with polycystic ovary syndrome. Hum. Reprod.https:\/\/doi.org\/10.1093\/humrep\/deu114","DOI":"10.1093\/humrep\/deu114"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00027","doi-asserted-by":"crossref","unstructured":"Visser, J.A., 2003. AMH signaling: From receptor to target gene, in: Molecular and Cellular Endocrinology.https:\/\/doi.org\/10.1016\/j.mce.2003.09.012","DOI":"10.1016\/j.mce.2003.09.012"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00028","doi-asserted-by":"crossref","unstructured":"Visser, J.A., Themmen, A.P.N., 2005. Anti-M\u00fcllerian hormone and folliculogenesis, in: Molecular and Cellular Endocrinology.https:\/\/doi.org\/10.1016\/j.mce.2004.09.008","DOI":"10.1016\/j.mce.2004.09.008"},{"key":"10.1016\/j.rbmo.2020.01.032_bib00029","doi-asserted-by":"crossref","unstructured":"Wang, J., Dicken, C., Lustbader, J.W., Tortoriello, D. V., 2009. Evidence for a M\u00fcllerian-inhibiting substance autocrine\/paracrine system in adult human endometrium. Fertil. Steril.https:\/\/doi.org\/10.1016\/j.fertnstert.2008.01.028","DOI":"10.1016\/j.fertnstert.2008.01.028"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648320300912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648320300912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:58:13Z","timestamp":1778813893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648320300912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1472648320300912"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2020.01.032","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometrial expression of anti-M\u00fcllerian hormone and its type II receptor in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2020.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}